As of June 30, 2021, Slate Path’s 13F portfolio had over $1.79 billion in managed securities. Slate Path invests in a variety of industries, including services, basic materials, and industrial goods. The top five holdings of Slate Path Capital account for roughly 46.45% of the portfolio. Compared to the first quarter of the year, the overall value of the holdings has increased by 1.16 percent. Coinbase Global, Stitch Fix, and Charter Communications were among the top companies in the investing portfolio after the second quarter of 2021.
Here is Insider Monkey’s list of top stocks David Greenspan’s Slate Path Capital is buying. Slate Path Capital had 420 thousand shares in the health-care company, valued at $12.7 million, and it makes up 0.7 percent of the hedge fund’s 13F portfolio as a new investment. In 1955, Vaneck Vectors Etf Tr was established. During the second quarter, Slate Path Capital made a fresh stake in Vaneck. Slate Path owned 285,000 shares of the New York-based company in the second quarter. Slate Path Capital upped its investment in Chromcraft to 690,000 shares, valued at $27.9 million. Chromcraft Revington Inc, a furniture company situated in Senatobia, Mississippi, was founded in 1955. Slate Path Capital purchased another 600,000 shares of the company in the second quarter of 2021. Comstock Resources, Inc. is rated 7th. Cyclerion Therapeutics, Inc., a health-care company situated in Cambridge, Massachusetts, was founded in 2018. Slate Path Capital held 7 million shares worth $27.9 million in the second quarter of 2021. For more details, click Top Stocks David Greenspan’s Slate Path Capital is Buying.
Unsplash
